Tags

Type your tag names separated by a space and hit enter

Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge.
Mult Scler Relat Disord. 2020 06; 41:102097.MS

Links

Publisher Full Text
ncbi.nlm.nih.gov
linkinghub.elsevier.com
PMC Free PDF

Authors+Show Affiliations

Carnero Contentti E
Neuroimmunology Unit, Department of Neuroscience, Hospital Alemán, Av Pueyrredón 1640, C1118AAT Buenos Aires, Argentina. Electronic address: ecarnerocontentti@hospitalaleman.com.
Correa J
Department of Infectious Diseases, Hospital Francisco J. Muñiz, Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.

MeSH

Antibodies, Monoclonal, HumanizedBetacoronavirusCOVID-19Coronavirus InfectionsCytokine Release SyndromeDeprescriptionsHumansImmunosuppressive AgentsNeuromyelitis OpticaPandemicsPneumonia, ViralRisk FactorsSARS-CoV-2Severity of Illness Index

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32278860

Citation

Carnero Contentti, Edgar, and Jorge Correa. "Immunosuppression During the COVID-19 Pandemic in Neuromyelitis Optica Spectrum Disorders Patients: a New Challenge." Multiple Sclerosis and Related Disorders, vol. 41, 2020, p. 102097.
Carnero Contentti E, Correa J. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Mult Scler Relat Disord. 2020;41:102097.
Carnero Contentti, E., & Correa, J. (2020). Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Multiple Sclerosis and Related Disorders, 41, 102097. https://doi.org/10.1016/j.msard.2020.102097
Carnero Contentti E, Correa J. Immunosuppression During the COVID-19 Pandemic in Neuromyelitis Optica Spectrum Disorders Patients: a New Challenge. Mult Scler Relat Disord. 2020;41:102097. PubMed PMID: 32278860.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. AU - Carnero Contentti,Edgar, AU - Correa,Jorge, Y1 - 2020/04/05/ PY - 2020/04/02/received PY - 2020/04/03/accepted PY - 2020/4/13/pubmed PY - 2020/7/3/medline PY - 2020/4/13/entrez SP - 102097 EP - 102097 JF - Multiple sclerosis and related disorders JO - Mult Scler Relat Disord VL - 41 SN - 2211-0356 UR - https://www.unboundmedicine.com/medline/citation/32278860/Immunosuppression_during_the_COVID_19_pandemic_in_neuromyelitis_optica_spectrum_disorders_patients:_A_new_challenge_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2211-0348(20)30174-7 DB - PRIME DP - Unbound Medicine ER -